Andrew Ewald, PhD
Dr. Andrew Ewald is an Associate Professor of Cell Biology, Oncology, and Biomedical Engineering at the Johns Hopkins University School of Medicine. His studies how cells build organs and how these same cellular processes can contribute to breast cancer metastasis. Dr. Ewald’s research lab recently identified a unique class of breast cancer cells that lead the process of invasion into surrounding tissues—a first step in cancer metastasis. Further research is planned to examine if these cells are viable targets for therapy
Dr. Ewald received his undergraduate degree in physics with honors from Haverford College. He earned his Ph.D. in biochemistry and molecular physics from the California Institute of Technology, studying with Scott Fraser. He completed postdoctoral work with Zena Werb in mammary biology and cancer at the University of California, San Francisco. Dr. Ewald joined the Johns Hopkins faculty in 2008.
He is a member of the American Association for Cancer Research, Society for Developmental Biology, and the American Society for Cell Biology. He is a fellow of the Keith R. Porter Endowment for Cell Biology and his work has been recognized with the AAA’s 2011 Morphological Sciences, the SPIE’s 2015 Systems Biology Pioneer Award, and the MBCN’s 2015 Metastatic Breast Cancer Research Leadership Award.
Andrew Ewald is an interdisciplinary cell and cancer biologist whose laboratory investigates how cells collectively drive changes in the structure and function of epithelial tissues
- Rangos 452